Abstract LB242: Discovery and characterization of BRSD-143, an orally bioavailable panKRAS inhibitor
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Charles Y. Cho, Qian Liu, Jun Liu, Deborah A. Knee, David P. Kodack, Dean P. Phillips, Phillip B. Alper, Hong Jin, Wendy Richmond, Sarah E. Kochanek, Hong Yin, Yu Chen, Jie Li, Cyrus Virata, David H. Jones, Jose C. Juarez, Michael DiDonato, Brandon L. Taylor, Dmitry Borkin, Dong Han, Xianzhong Liu, Vicki W. Zhou, Lilin Li, Rita Das, Varunika Vivekanandan, Flavio Somanji, David A. Ruddy, Michelle Piquet, Miriam Coor, Eiru Kim, Yelena Sarkisova, Min Lu, Guoxun Liu, Danielle Roman, William P. Gordon, Todd Groessl, Michael Shapiro, Yvonne Wang, Darbi Witmer, Agnes Vidal-Biggart, Yong Jia, Jacob R. Haling
Institution: Novartis (Switzerland)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409820763